Losartan and Right ventricular dysfunction - a phase IV clinical study of FDA data

Summary:

Right ventricular dysfunction is reported as a side effect among people who take Losartan (losartan potassium), especially for people who are male, 30-39 old, also take Amlodipine, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Right ventricular dysfunction when taking Losartan. It is created by eHealthMe based on reports of 170,768 people who have side effects when taking Losartan from the FDA, and is updated regularly.

What is Losartan?

Losartan has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 177,686 Losartan users. Check the latest studies of Losartan.

What is Right ventricular dysfunction?

Right ventricular dysfunction is found to be associated with 186 drugs and 250 conditions by eHealthMe. Check the latest studies of Right ventricular dysfunction.

On Jul, 19, 2026

170,768 people reported to have side effects when taking Losartan.
Among them, 16 people (0.01%) have Right ventricular dysfunction.

Could Losartan cause Right ventricular dysfunction?

Among these 16 people:

What is the gender of people who have Right ventricular dysfunction when taking Losartan? *

female: 50 %
male: 50 %

What is the age of people who have Right ventricular dysfunction when taking Losartan? *

What are other drugs people take besides Losartan? *

What are other side effects people have besides Right ventricular dysfunction? *

Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 7 people, 43.75%
Headache (pain in head): 4 people, 25.00%
Tricuspid Valve Incompetence (inefficient heart valve): 2 people, 12.50%
Lung Disorder (lung disease): 2 people, 12.50%
Left Ventricular Dysfunction: 2 people, 12.50%
Hypoaesthesia (reduced sense of touch or sensation): 1 person, 6.25%
Joint Pain: 1 person, 6.25%
Heart Sounds Abnormal: 1 person, 6.25%
Heart Rate Increased: 1 person, 6.25%
Death: 1 person, 6.25%

What are the existing conditions these people have? *

Malignant Melanoma (skin cancer rises from melancytes): 2 people, 12.50%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 12.50%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 12.50%
Sinusitis (inflammation of sinus): 1 person, 6.25%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 6.25%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 6.25%
Prostate Cancer: 1 person, 6.25%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 6.25%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 1 person, 6.25%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Losartan and have Right ventricular dysfunction?

- Check whether Right ventricular dysfunction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Losartan:

Losartan (177,686 reports)

Browse all side effects of Losartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Right ventricular dysfunction:

Right ventricular dysfunction (186 drugs)

Browse all the conditions that are associated with Right ventricular dysfunction:

Right ventricular dysfunction (250 conditions)

Related publications that referenced our studies

Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .
Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on losartan potassium (the active ingredients of Losartan) and Losartan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.